James Deluca

About James Deluca

Most multi-location dental founders are flying blind into an institutional ambush.They go to market expecting a 10x \"Platform\" valuation based on top-line revenue, completely unaware that their clinical data architecture is severely fragmented. When the Private Equity buyer\'s Quality of Earnings (QofE) team deploys, they weaponize this un-auditable clinical variance to downgrade the asset to an \"Add-on,\" instantly vaporizing millions in Enterprise Value.As the Founder of Precision Dental Analytics, I execute Clinical Data Forensics and M&A Defense exclusively for sell-side founders and their brokers. Having previously directed operations inside major national DSOs, I know exactly the clinical tripwires institutional buyers use to compress your multiple—and how to mathematically defend against them.We are the \"Red Team\" for eight-figure dental exits.Pre-LOI Forensic Data SanitizationStandard CPAs audit the General Ledger; we audit the clinical reality. Before you sign an LOI and trigger the NDA gag order, we extract your raw Practice Management Software data. We sanitize provider-level coding drift, eliminate \"hollow growth\" anomalies, and mathematically harden your clinical architecture to ensure your EBITDA survives institutional due diligence.Protecting the 10x MultipleWe partner directly with elite M&A brokers to ensure the valuations they take to market are mathematically defensible. We bridge the gap between clinical reality and institutional finance, ensuring founders do not fund the buyer\'s acquisition with their own lost equity.Do not deploy into a bid process on the assumption of data integrity. Unmask your forensics, or prepare to fund the deficit.Author of: Spartan Leadership The Dental Data Playbook Hidden LeversTo initiate a Pre-LOI Feasibility Review and lock down your clinical architecture, contact me directly.

Experience

1. Founder

   Precision Dental Analytics

   Dec 2022 — Present · Gallipolis, OH, US

   Precision Dental Analytics is a specialized intelligence firm protecting institutional capital and maximizing enterprise value in the dental M&A sector. We bridge the critical gap in standard financial due diligence by verifying the clinical origins of practice revenue.For Private Equity & DSOs We execute pre-close forensic clinical audits, benchmarking CDT utilization against national compliance standards to unmask \"Phantom EBITDA\". We identify systemic code-stacking and unbundling, allowing deal teams to calculate a \"Sanitized EBITDA\" and avoid multi-million dollar compliance haircuts post-acquisition.For Elite Practice Owners We engineer institutional-grade exits. By shifting the financial architecture from tax optimization to true EBITDA optimization, we sanitize operations, mitigate associate misclassification risks, and codify clinical systems to completely eliminate owner dependency prior to market entry.